Compare Organon Pharma Indonesia Tbk. (SCPI) vs Siwani Makmur Tbk (SIMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Siwani Makmur Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Siwani Makmur Tbk trades at Rp50 (market cap 22.13B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 4.7× Siwani Makmur Tbk's market cap. Which is the better fit depends on your goals.
| SCPI | SIMA | |
|---|---|---|
Market Cap | 104.4B | 22.13B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Siwani Makmur Tbk
PT Siwani Makmur Tbk (the Company) was established under the name PT Super Indah Makmur based on Notarial Deed No. 43 dated June 7, 1985 of Wiryomartani, SH. On September 23, 1996 its changed the name to be PT Van Der Horst Indonesia, Tbk, and on February 20, 2001, it changed again its named to be PT Siwani Makmur, Tbk.
Read more on SIMA →
